Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT00499317 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Genetic Study of Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS)

Study acronym: CP/CPPS
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary completion date: Dec 31, 2025 to Dec 31, 2027 Completion date: Dec 31, 2026 to Dec 31, 2028v10 Show 1 more changeShow less
    • Completion date: Dec 31, 2026 to Dec 31, 2028
  2. Site contact updatedv9
  3. Site contact updatedv8
  4. Eligibility criteria expanded, about 8 words Study description expanded, about 15 wordsv7 Show 1 more changeShow less
    • Study description expanded, about 15 words

    See this version in full on ClinicalTrials.gov ↗

  5. Primary completion date: Dec 31, 2020 to Dec 31, 2025 Completion date: Dec 31, 2021 to Dec 31, 2026 · Study site revised · Eligibility criteria expanded, about 5 words · 1 morev6 Show 4 more changesShow less
    • Completion date: Dec 31, 2021 to Dec 31, 2026
    • Study site revised
    • Eligibility criteria expanded, about 5 words
    • Study description shortened, about 1 word

    See this version in full on ClinicalTrials.gov ↗

Show 4 earlier versionsHide 4 earlier versions
  1. Study description expanded, about 25 wordsv5 See this version in full on ClinicalTrials.gov ↗
  2. Primary completion date: Dec 31, 2020 Completion date: Jun 2012 to Dec 31, 2021 · Start date: Jan 2007 to Jan 15, 2007 · Eligibility criteria expanded, about 14 words · 4 morev4 Show 7 more changesShow less
    • Completion date: Jun 2012 to Dec 31, 2021
    • Start date: Jan 2007 to Jan 15, 2007
    • Eligibility criteria expanded, about 14 words
    • Site contact updated
    • Publications revised (3)
    • Study description shortened, about 4 words
    • Collaborators shortened, about 5 words

    See this version in full on ClinicalTrials.gov ↗

  3. Completion date: Jan 2011 to Jun 2012 Site contact updated · Eligibility criteria expanded, about 5 words · Collaborators expanded, about 5 wordsv3 Show 3 more changesShow less
    • Site contact updated
    • Eligibility criteria expanded, about 5 words
    • Collaborators expanded, about 5 words

    See this version in full on ClinicalTrials.gov ↗

  4. Enrollment target: 100 to 500 Completion date: Jan 2009 to Jan 2011 · Eligibility criteria expanded, about 6 words · Study description expanded, about 22 wordsv2 Show 3 more changesShow less
    • Completion date: Jan 2009 to Jan 2011
    • Eligibility criteria expanded, about 6 words
    • Study description expanded, about 22 words

    See this version in full on ClinicalTrials.gov ↗

  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS) is a condition with several causes of which some remain unknown. It is believed that some types of CP may be genetic or passed down (inherited) from one generation to the next. In this study, we are collecting genetic material and medical information to try to determine if genetic factors play a role in CP/CPPS. We will be collecting DNA (from Blood/Saliva sample) and urine from each participant. Bladder tissue from affected individuals will also be collected. Individuals and families with CP/CPPS will be enrolled. Family members of an individual with CP/CPPS are eligible whether or not they also experience CP/CPPS symptoms.
Trial Details
NCT Number NCT00499317
Lead Sponsor Boston Children's Hospital
Conditions Chronic Prostatitis (CP), Chronic Pelvic Pain Syndrome (CPPS), Painful Bladder Syndrome (PBS), Benign Frequency Syndrome (BFS), Interstitial Cystitis
Enrollment 500 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov